Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer

BACKGROUND: Identification of diagnostic and prognostic biomarkers is a research priority for the improved management of pancreatic ductal adenocarcinoma (PDAC). Insulin-like growth factor binding protein 2 (IGFBP2) and mesothelin (MSLN) have shown potential as serum biomarkers in other cancers, but...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kendrick, Zachary W, Firpo, Matthew A, Repko, Robert C, Scaife, Courtney L, Adler, Douglas G, Boucher, Kenneth M, Mulvihill, Sean J
Format: Artigo
Langue:Inglês
Publié: BlackWell Publishing Ltd 2014
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4105906/
https://ncbi.nlm.nih.gov/pubmed/24308545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hpb.12199
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires